- CLRB Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1/A Filing
Cellectar Biosciences (CLRB) S-1/AIPO registration (amended)
Filed: 7 Jul 10, 12:00am
![]() | 155 Seaport Boulevard Boston, MA 02210-2600 617 832 1000 main 617 832 7000 fax |
July 6, 2010 | 617 832 1113 direct pbork@foleyhoag.com |
Via Edgar |
Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, DC 20549 Attn: Bryan J. Pitko |
Re: | Novelos Therapeutics, Inc. Amendment No. 2 to Registration Statement on Form S-1 File No. 333-166744 |
· | To include in the prospectus the number of units to be sold in the offering, the number of shares of common stock and warrants per unit, the number of shares purchasable under the warrants, the exercise price of the warrants and the exercise period for the warrants, each, respectively, as information requested by the Commission in the first page of its letter dated June 29, 2010; and |
BOSTON | WASHINGTON | EMERGING ENTERPRISE CENTER | FOLEYHOAG.COM |
· | To update the disclosure as necessary to reflect events occurring since the filing of Amendment No. 1 to the Registration Statement with the Commission on May 25, 2010 (the “Previous Amendment”). |
Very truly yours, | ||
/s/ Paul Bork | ||
Paul Bork |
Mr. Harry Palmin |
Mr. Matthew Eckert |